Gene
CITED2
Cbp/p300 interacting transactivator with ED-rich tail 2
Explore in graph →CI-GENE-00041449HGNC:1987 ENSG00000164442 NCBI 10370 Approved
Curated evidence
Clinical evidence (1)
CIViC items involving this gene, grouped by molecular profile and therapy, with native levels and directions. 50 items per page.
civicProvenance
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 38000680
- Run
- ING-CIVIC-20260908-000001
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| CITED2 Fusion + NCOA3 Fusion + ESR1 Fusion + NCOA2 Fusion + GREB1 FusionNCOA3NCOA2CITED2ESR1GREB11 | ||||||||
| (prognostic) | Malignant Uterine NeoplasmALIAS | Prognostic | C | Supports Poor Outcome | 1 | submitted | EID12707In a retrospective UTROSCT cohort (n = 17, follow-up n = 13), 3 patients (23.1%) carrying GREB1::NCOA2, ESR1::NCOA3 or ESR1::CITED2 fusions developed pelvic, abdominal or pulmonary recurrence, with re… (full text at CIViC) PMID 38000680 · Qijun et al., 2024 · Open in CIViC | civic |
Cohorts
Alteration frequency by cohort (0)
Frequency = cases affected / cases profiled within one cohort. Cohorts are never pooled.
Data not yet available
No cohort frequency recorded for this gene.
Literature
Linked publications (0)
Data not yet available
No publication linked to this gene yet.